Pancreatic neuroendocrine tumors (pNETs) are frequently malignant (50-80%, except for insulinoma) and may show an aggressive course with metastases to the liver as well as more distant sites. These heterogeneous neoplasms include functioning tumors, which secrete a variety of peptide hormones, and non-functioning tumors (up to 90% of pNETs), which often show metastases at the time of diagnosis.

Therapy for metastatic pancreatic neuroendocrine tumors / R.E. Rossi, S. Massironi, D. Conte, M. Peracchi. - In: ANNALS OF TRANSLATIONAL MEDICINE. - ISSN 2305-5839. - 2:1(2014 Jan), pp. 8.1-8.12. [10.3978/j.issn.2305-5839.2013.03.01]

Therapy for metastatic pancreatic neuroendocrine tumors

R.E. Rossi
Primo
;
S. Massironi
Secondo
;
D. Conte
Penultimo
;
M. Peracchi
Ultimo
2014

Abstract

Pancreatic neuroendocrine tumors (pNETs) are frequently malignant (50-80%, except for insulinoma) and may show an aggressive course with metastases to the liver as well as more distant sites. These heterogeneous neoplasms include functioning tumors, which secrete a variety of peptide hormones, and non-functioning tumors (up to 90% of pNETs), which often show metastases at the time of diagnosis.
pancreatic neuroendocrine tumors (pNETs); duodenocephalopancreasectomy; liver metastases; liver transplantation; liver-directed therapies; somatostatin analogues
Settore MED/12 - Gastroenterologia
gen-2014
Article (author)
File in questo prodotto:
File Dimensione Formato  
1730-PB5-R4.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 245.62 kB
Formato Adobe PDF
245.62 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/434195
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus 29
  • ???jsp.display-item.citation.isi??? ND
social impact